浏览全部资源
扫码关注微信
成都中医药大学,成都 611137
Published:20 November 2019,
Published Online:18 July 2019,
Received:27 March 2019,
扫 描 看 全 文
Cong HUANG, Wei PENG, Da-neng WEI, et al. Effect of Pinelliae Rhizoma Praeparatum Cum Alumine Polysaccharides on MUC5AC mRNA in Lung Tissues of Allergic Asthma Model Rats. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):15-21(2019)
Cong HUANG, Wei PENG, Da-neng WEI, et al. Effect of Pinelliae Rhizoma Praeparatum Cum Alumine Polysaccharides on MUC5AC mRNA in Lung Tissues of Allergic Asthma Model Rats. [J]. Chinese Journal of Experimental Traditional Medical Formulae 25(22):15-21(2019) DOI: 10.13422/j.cnki.syfjx.20192103.
目的:
2
通过观察清半夏多糖对过敏性哮喘模型大鼠气道黏液分泌的作用,研究清半夏多糖为原药材发挥“燥湿化痰”功效“大分子”成分的物质作用基础。
方法:
2
SPF级Wistar大鼠60只,除正常组外,鸡卵清蛋白(OVA)与铝镁佐剂腹腔注射诱导致敏,OVA溶液雾化激发,建立过敏性哮喘大鼠模型。造模成功后大鼠随机平均分成5组,为过敏性哮喘模型组,阳性药组(孟鲁司特钠,5 mg·kg
-1
),清半夏多糖高、中、低剂量组(400,200,100 mg·kg
-1
)。酶联免疫吸附测定(ELISA)检测血清、支气管肺泡灌洗液(BALF)上清液中白细胞介素-4(IL-4),
γ
-干扰素(IFN-
γ
)含量,BALF沉渣进行嗜酸性粒细胞(EOS)的计数检测;苏木素-伊红(HE)染色观察肺组织病理改变,实时荧光定量聚合酶链式反应(Real-time PCR)检测肺组织黏蛋白5AC(MUC5AC)mRNA的表达。
结果:
2
与正常组比较,过敏性哮喘模型组大鼠血清IL-4含量显著升高(
P
<
0.01),IFN-
γ
含量显著降低(
P
<
0.01),BALF中EOS计数显著升高(
P
<
0.01);与过敏性哮喘模型组比较,孟鲁司特钠组、清半夏多糖高、中、低剂量组均能显著降低血清中IL-4的含量(
P
<
0.01),清半夏多糖高、中剂量组能显著降低BALF中IL-4的含量(
P
<
0.05,
P
<
0.01),清半夏多糖中剂量组能显著增高血清中IFN-
γ
的含量(
P
<
0.05),孟鲁司特钠组、清半夏多糖各剂量组均能显著降低BALF中的EOS计数(
P
<
0.01)。HE染色结果显示,过敏性哮喘模型组大鼠肺组织出现明显病理改变,孟鲁司特钠组、清半夏多糖各组具有缓解作用。与正常组比较,过敏性哮喘模型组大鼠肺组织的MUC5AC mRNA表达显著升高(
P
<
0.01);与过敏性哮喘模型组比较,孟鲁司特钠组、清半夏多糖高、中、低剂量组MUC5AC mRNA均显著降低(
P
<
0.01)。
结论:
2
清半夏的“大分子”成分清半夏多糖,可能是原药材清半夏发挥“燥湿化痰”功效的物质作用基础。
Objective:
2
To observe the effect of Pinelliae Rhizoma Praeparatum Cum Alumine polysaccharides(PRPCAP)on airway mucus secretion in rats with allergic asthma
in order to study the material basis of the " macromolecule" component of the polysaccharides as the original medicinal materials.
Method:
2
The 60 SPF-grade Wistar rats were induced by intraperitoneal injection of chicken ovalbumin (OVA) and aluminum-magnesium adjuvant
except for the normal control group. The OVA solution was aerosolized to establish a rat model of allergic asthma. After successful modeling
the rats were randomly divided into 5 groups
namely allergic asthma model group
positive drug group (montalurast sodium
5 mg·kg
-1
)
high-dose PRPCAP group (400 mg·kg
-1
)
middle-dose PRPCAP group (200 mg·kg
-1
) and low-dose PRPCAP group (100 mg·kg
-1
). The contents of interleukin-4 (IL-4) and interferon-
γ
(IFN-
γ
) in serum and bronchoalveolar lavage fluid (BALF) supernatant were determined by enzyme-linked immunosorbent assay (ELISA)
and the count of eosinophils (EOS) was detected by BALF sediment. The histopathological changes were observed by hematoxylin-eosin (HE) staining in lung tissue. The mRNA expression of mucin 5AC (MUC5AC) was detected by Real-time fluorescent quantitative polymerase chain reaction (Real-time PCR).
Result:
2
Compared with the normal control group
serum IL-4 level in the allergic asthma model group was significantly increased (
P
<
0.01)
IFN-
γ
level was significantly decreased (
P
<
0.01)
and EOS counts in BALF were significantly increased (
P
<
0.01). Compared with the allergic asthma model group
the positive drug group
and high
middle
and low-dose PRPCAP groups could significantly reduce the serum IL-4 content (
P
<
0.01)
while high and middle-dose PRPCAP groups could significantly reduce the content of IL-4 in BALF (
P
<
0.05
P
<
0.01)
the middle-dose PRPCAP group could significantly increase the content of IFN-
γ
in serum (
P
<
0.05)
EOS counts in BALF were significantly lower in the positive drug group and all of PRPCAP groups (
P
<
0.01). HE staining showed the pathological changes in the lung tissue of the allergic asthma model group and a mitigating effect in the positive drug group and all of PRPCAP groups. Compared with the normal control group
the expression of MUC5AC mRNA in the lung tissue of rats with allergic asthma was significantly increased (
P
<
0.01). Compared with the model group of allergic asthma rats
the positive drug group and all of PRPCAP groups showed significant decrease in MUC5AC mRNA (
P
<
0.01).
Conclusion:
2
The " macromolecule" component of polysaccharides in the Pinelliae Rhizoma Praeparatum Cum Alumine may be the material basis for the efficacy of eliminating dampness and eliminating phlegm.
清半夏多糖过敏性哮喘模型大鼠黏蛋白5AC(MUC5AC)
Pinelliae Rhizoma Praeparatum Cum Alumine polysaccharidesallergic asthma model ratmucin 5AC (MUC5AC)
崔红梅,范玉强.栗锦迁从痰论治眩晕经验[J].湖南中医杂志,2018,34(1):24-25.
王烈,苏培迪,郭磊,等.论“哮痰汤”治“哮痰证”[J].湖南中医杂志,2017,33(10):29-30.
李斌,程秀民,周永妍,等.半夏的研究进展[J].中国民族民间医药,2010,19(1):47-48.
刘娟娟,张婷,米芋枚.呼吸道合胞病毒感染对气道上皮细胞表皮生长因子受体、紧密连接相关蛋白及黏蛋白表达的影响[J].中国当代儿科杂志,2019,21(3):294-299.
王艳杰,苗兰英,柳春,等.脾虚哮喘模型大鼠肺组织MUC5AC蛋白表达变化的研究[J].时珍国医国药,2013,24(10):2551-2553.
张博达.基于CysLts探讨三子养亲汤抑制OVA致大鼠哮喘气道黏液高分泌的作用机制研究[D].成都:成都中医药大学,2018.
潘杰.过敏性哮喘小青龙汤证动物模型述评[J].山东中医药大学学报,2010,34(4):322-323.
刘兴隆,张珑琼,付雯,等.“肺肠合治”法对肠道菌群失调合并过敏性哮喘大鼠呼吸功能、肠菌群及相关免疫因子的影响研究[J].辽宁中医杂志,2017,44(8):1748-1752.
徐凤,肖韩艳,周淑芬,等.柴朴汤对哮喘模型大鼠气道炎症及ERK/p38 MAPK信号通路的影响[J].中国实验方剂学杂志,2018,24(2):104-109.
崔佳丽.孟鲁斯特对哮喘大鼠IL-25、IL-12及NF-κB、MMP-9表达的影响[D].石家庄:河北医科大学,2010.
王世华,付靖,刘少琴,等.正交试验优选清半夏的炮制工艺[J].中国实验方剂学杂志,2014,20(19):25-28.
周信,张小荣,张秋燕,等.生半夏及其炮制品对小鼠主动脉内皮细胞炎性因子分泌的影响[J].中国实验方剂学杂志,2013,19(10):261-265.
张明发,沈雅琴.半夏提取物抗菌抗炎及其抗肿瘤药理作用研究进展[J].抗感染药学,2017,14(6):1089-1094.
黄桂红,韦江红,陈薇,等.黄皮叶提取物对哮喘大鼠血清及肺组织Th1/Th2平衡的调节作用[J].中国实验方剂学杂志,2015,21(19):97-100.
孙小钧.肺肠合治、治肺、治肠法对肠道菌群失调并过敏性哮喘大鼠TGF-β1/Smads信号传导通路影响的比较研究[D].成都:成都中医药大学,2016.
秦乐.桂枝加厚朴杏子汤干预肠道菌群失调合并过敏性哮喘大鼠Th17/Treg细胞平衡相关调节因子的实验研究[D].成都:成都中医药大学,2015.
付雯.基于肠道茵群失调并过敏性哮喘大鼠TLRs/NF-κB信号转导通路及肠道茵群16SrDNA的“肺与大肠相表里"免疫机制研究[D].成都:成都中医药大学,2015.
董春玲,鲁继荣,王桂芳,等.哮喘小鼠肺组织中水通道蛋5和黏蛋白5AC的表达变化及其相关性研究[J].中国现代医学杂志,2007,17(24):2962-2965.
Inoue D, Kubo H, Sasaki T, et al. Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14 [J].Respirol, 2008, 13(2): 215-220.
邢琼琼,赵霞,杨睿雪,等.固本防哮饮对支气管哮喘缓解期小鼠嗜酸性粒细胞及黏液分泌相关因子的影响[J].中医杂志,2017,58(18):1581-1584.
魏然,臧金萍,王金亮,等.IL-12在哮喘小鼠杯状细胞化生和黏液分泌中的作用[J].中华哮喘杂志:电子版,2013,7(1):14-16.
0
Views
8
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution